Silver Book Fact

Baseline lung cancer screening would lead to more than 130,000 additional survivors in 2012.

Pysenson B, Sander M, Jiang Y, Kahn H, et al. An Actuarial Analysis Shows That Offering Lung Cancer Screening As An Insurance Benefit Would Save Lives At Relatively Low Cost. Health Aff. 2012; 31(4): 770-779. https://www.healthaffairs.org/doi/abs/10.1377/hlthaff.2011.0814?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dpubmed

Reference

Title
An Actuarial Analysis Shows That Offering Lung Cancer Screening As An Insurance Benefit Would Save Lives At Relatively Low Cost
Publication
Health Aff
Publisher
Project HOPE
Publication Date
2012
Authors
Pysenson B, Sander M, Jiang Y, Kahn H, et al
Volume & Issue
Volume 31, Issue 4
Pages
770-779
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Cervical cancer screening reduces incidence by over 80%.  
  • Use of a monocolonal antibody with adjuvant chemotherapy in HER2+ individuals with operable cancer was associated with a 33 percent reduction in risk of death.  
  • A modest 1% reduction in cancer mortality would be worth close to $500 billion. A cure for cancer (if one is feasible) would be worth around $50 trillion.  
  • FDA Cancer Approvals for Aug 2014 to July 2015
     
  • Surgical biopsy for lumps in the breast was found by one study to cost 2 1/2 to 3 times more than image-guided core-needle biopsy ($698 versus $243).